The Impact of TRPM8 on Prostate Cancer Transcriptomic Dynamics
Cells · 2025
DOI: 10.3390/cells14070501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Swapna Asuthkar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA. Hauptthemen laut MEDLINE: TRPM Cation Channels, Prostatic Neoplasms, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Willian E. McElroy Charitable Foundation, William E. McElroy Charitable Foundation, Springfield, Illinois.
Abstract (Originalsprache)
Prostate cancer (PC) remains a significant health challenge, with androgen receptor (AR) signaling playing a pivotal role in its progression. This study investigates the expression and functional implications of the transient receptor potential melastatin 8 (TRPM8) channel in PC, focusing on its interaction with AR and its impact on oncogenic pathways. We analyzed mRNA expression levels of TRPM8 and AR in PC tissues, revealing that TRPM8 is upregulated in benign and early-stage tumors but significantly downregulated in metastatic samples. This decline correlates with increased AR expression, suggesting a compensatory mechanism that enhances AR-driven tumorigenesis. RNA sequencing and pathway enrichment analyses demonstrated that TRPM8 knockout (KO) prostates exhibited significant alterations in gene expression, particularly in pathways related to extracellular matrix (ECM) remodeling, cell proliferation, and survival signaling. Notably, genes associated with metastasis, such as MMP2 and FAP, were upregulated in TRPM8 KO samples, indicating a potential role for TRPM8 in inhibiting tumor invasion. Furthermore, Gene Set Enrichment Analysis (GSEA) revealed positive enrichment of androgen response, angiogenesis, and epithelial–mesenchymal transition (EMT) pathways in TRPM8 KO prostates, reinforcing the notion that TRPM8 loss creates a pro-tumorigenic environment. Our findings suggest that TRPM8 functions as a molecular brake on PC progression, and its loss may contribute to the development of aggressive disease phenotypes. This study underscores the importance of TRPM8 as a potential therapeutic target and biomarker in PC, warranting further investigation into its role in cancer biology and treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA.
- Department of Pediatrics, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA.
- Pringle Robotics, Peoria, IL 61614, USA.
- OSF Saint Francis Medical Center, Peoria, IL 61637, USA.
- Department of Psychology, Bradley University, Peoria, IL 61625, USA.
- Department of Pathology, University of Illinois at Chicago, Chicago, IL 60614, USA.
ORCID-Profile: Swapna Asuthkar, Erick B Saldes, Benny Tom, Donald J Vander Griend
Förderung
- Willian E. McElroy Charitable Foundation
- William E. McElroy Charitable Foundation, Springfield, Illinois
Zitieren
APA
Asuthkar, S., Bayen, S., Saldes, E. B., Tom, B., Velpula, J., Siddharth, S., Koeltzow, T. E., & Vander Griend, D. J. (2025). The Impact of TRPM8 on Prostate Cancer Transcriptomic Dynamics. Cells. https://doi.org/10.3390/cells14070501
Vancouver
Asuthkar S, Bayen S, Saldes EB, Tom B, Velpula J, Siddharth S, et al. The Impact of TRPM8 on Prostate Cancer Transcriptomic Dynamics. Cells. 2025. doi:10.3390/cells14070501
BibTeX
@article{Asuthkar2025,
author = {Asuthkar, Swapna and Bayen, Susovon and Saldes, Erick B and Tom, Benny and Velpula, Jai and Siddharth, Sarangi and Koeltzow, Timothy E and Vander Griend, Donald J},
title = {The Impact of TRPM8 on Prostate Cancer Transcriptomic Dynamics},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14070501}
}
EUVIMED